# Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

> **NCT07671495** · PHASE2 · COMPLETED · sponsor: **MIPO Clinic** · enrollment: 278 (actual)

## Conditions studied

- Melanoma Stage I
- Melanoma Stage III
- Melanoma Stage II
- Skin Melanoma

## Interventions

- **PROCEDURE:** Surgical resection
- **RADIATION:** Adjuvant Radiotherapy
- **BIOLOGICAL:** interferon alfa
- **DRUG:** Dacarbazine (DTIC)
- **DRUG:** Cisplatin
- **DIAGNOSTIC_TEST:** Immunological Monitoring
- **DIAGNOSTIC_TEST:** Skinscope Dermatoscopy

## Key facts

- **NCT ID:** NCT07671495
- **Lead sponsor:** MIPO Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2026-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671495, "Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*